Business
Currency:CHF
2023/FY
Stock NameRevenueRatio
Research, development and commercialization of biopharmaceutical products6.03M100.00%
Region
Currency:CHF
2023/FY
Stock NameRevenueRatio
Europe (Excluding Switzerland)2.89M47.84%
North America1.41M23.31%
Rest of the world1.33M22.00%
Switzerland414K6.86%
